PlatformsAustralian Brain Bank Network (ABBN)

2004

Barnham KJ, Masters CL, Bush AI (2004). Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205-14.

Buckley ST, Dodd PR (2004). GABAA receptor subunit mRNA expression in the human alcoholic brain. Neurochem. Internat 45, 1011-1020.

Cai Z, Blumbergs PC, Koblar SA, Cash K, Manavis J, Ghabriel MN, Thompson PD (2004). Peripheral nervous system and central nervous system pathology in rapidly progressive lower motor neuron syndrome with immunoglobulin M anti-GM1 ganglioside antibody. J Peripher Nerv Syst 9(2):79-91.

Cooper WA, Shingde M, Lee VK, Allan RS, Wills EJ, Harper C (2004). Rhabdoid meningioma lacking malignant features - report of two cases. Clin Neuropathol 23(1): 16-20.

Culvenor JG, Ilaya NT, Ryan MT, Hoke DE, Williamson NA, McLean CA, Masters CL, Evin G (2004). Characterisations of presenilin complexes from mouse and human brain using blue native gel electrophoresis reveals high expression in embryonic brain and minimal change in complex mobility with pathogenic presenilin mutations. Eur J Biochem 271(2):375-85.

Dean B, Gray L, Keriakous, D, Scarr E (2004). A comparison of M1 and M4 receptors in the thalamus from control subjects and subjects with schizophrenia. Thalamus and Related Systems 2: 287-295.

Dean B (2004). The neurobiology of bipolar disorder: Findings using human post mortem central nervous system tissue. Aust N Z JPsychiatry 38: 135-140.

Dean B (2004). M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia. Neuropsychopharmacology 29 (8): 1583-1584.

Dean B (2004). The role of muscarinic1 receptors in the pathology of schizophrenia. Am J Med Genet 126B(1):8-9.

Dean B (2004). The neurobiology of bipolar disorder: Findings using human post mortem CNS tissue. Aust N Z J Psychiatry 38(3):135-40.

Dean B, Pavey G, Scarr E, Goeringer K, Copolov DL (2004). Measurement of Dopamine D2-like Receptors in Post mortem Caudate-Putamen and Pituitary: Differential Regional Changes in Schizophrenia. Life Sci 74(25):3115-31.

Dean B, Scarr E (2004). Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits. Curr Drug Targets CNS Neurol Disord. 3:217-25.

Dixon G, Garrick T, Whiteman I, Sarris M, Sithamparanathan S, Harper C (2004). Characterisation of GABAergic neurons within in human medial mamillary nucleus. Neuroscience 127(2) 365-372.

Dixon G, Harper CG (2004). No evidence for selective GABAergic interneuron deficits in the anterior thalamic complex of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28(6):1045-1051.

Dodd PR, Foley PF, Buckley ST, Eckert AL, Innes DJ (2004). Genes and gene expression in the brain of the alcoholic. Addictive Behaviours 29, 1295-1309.

Foley PF, Loh EW, Innes DJ, Williams SM, Tannenberg AEG, Harper CG, Dodd PR (2004). Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann. NY Acad. Sci1025, 39-46.

George AJ, Holsinger RM, McLean CA, Laughton KM, Beyreuther K, Evin G, Masters CL, Li QX (2004). APP intracellular domain is increased and soluble A? is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiol Dis 16(1):124-32.

Holsinger RM, McLean CA, Collins SJ, Masters CL, Evin G (2004). Increased ? -Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects. Ann Neurol 55(6):898-9.

Hynd MR, Scott HL, Dodd PR (2004). Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease. J Neurochem 89(1):240-7.

Hynd MR., Scott HL, Dodd PR (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Internat 45, 583-595.

Hynd MR, Scott HL, Dodd PR (2004). Differential expression of NMDA receptor NR2 isoforms in Alzheimer's disease. J. Neurochem 90, 913-919.

Lewohl JM, Van Dyk DD, Craft G, Innes DJ, Mayfield RD, Cobon G, Harris RA, Dodd PR (2004). The application of proteomics to the human alcoholic brain. Ann. NY Acad. Sci 1025, 14-26.

Lindersson EK, Hojrup P, Gai WP, Locker D, Martin D, Jensen PH (2004). Alpha-synuclein filaments bind the transcriptional regulator HMGB-1. Neuroreport 15 (18): 2735-2739.

Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004). Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279(13):12924-34.

Liu J, Lewohl JM, Dodd PR, Randall PK, Harris RA, Mayfield RD (2004). Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain. J. Neurochem 90, 1050-1058.

Lowe R, Pountney DL, Jensen PH Gai WP, Voelcker NH (2004). Calcium (II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain. Protein Sci 13 (12): 3245-3252.

Masters CL (2004). Halford Oration - Testing the Amyloid Theory. Chiron 5:10-13.

Nadri C., Dean B, Scarr E, Agam G (2004). GSK-3 parameters in post mortem frontal cortex and hippocampus of schizophrenic patients. Schizophrenia Research 71: 377-382.

Pfefferbaum A., Sullivan E., Adalsteinsson E., Garrick T., Harper C (2004). Post mortem MR Imaging of Formalin-Fixed Human Brain. Neuromage Vol 21. 1585-1595.

Poljak A, McLean CA, Sachdev P, Brodaty H, Smthe GA (2004). Quantification of hemorphins in Alzheimer's disease brains. J Neurosci Res 75(5):704-14.

Pountney DL, Treweek TM, Chataway T, Huang Y, Chegini F, Blumbergs PC, Raftery MJ, Gai WP (2004). AlphaB-Crystallin is a major component of glial cytoplasmic inclusions in Multiple system atrophy. Neurotox Res 7 (1-2):77-85.

Ritchie CW, Bush AI, Masters CL (2004). Metal-protein attenuating compounds and Alzheimer's disease. Expert Opin Investig Drugs 13(12): 1585-92.

Scarr E, Pavey G, Copolov DL, Dean B (2004). Hippocampal 5-hydroxytryptamine receptors: Abnormalities in post mortem brain from schizophrenic subjects. Schizophrenia Research 71: 383-392.

Smith MJ, Sharples RA, Evin G, McLean CA, Dean B, Pavey G, Fantino E, Cotton RG, Imaizumi K, Masters CL, Cappai R, Culvenor JG (2004). Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex. Brain Res Mol Brain Res 127(1-2):128-135.

Tannenberg RK, Scott HL, Westphalen RI, Dodd PR (2004). The identification and characterization of excitotoxic nerve-endings in Alzheimer disease. Curr. Alzheimer Res 1, 11-25.

Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, Wesselingh SL, McLean CA (2004). Astrocyte specific viral strains in HIV dementia. Ann Neurol 56(6):873-7.

Thyagarajan D, Chataway T, Li R, Gai WP, Brenner M (2004). Dominantly-inherited adult-onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene. Mov Disord 19 (10): 1244-1248.

Van Den Bos M, Marotta R, Goldup S, Chataway T, Firgaira F, Thyagarajan D (2004). Writer's cramp in an Australian pedigree with DYT1 dystonia. J Clin Neurosci 11(5):537-9.

Verdile G et al (2004). Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 63 1385-1392.

Walton JR. (2004). A bright field/fluroescent stain for aluminium; its specificity, validation and staining characteristics. Biotechn Hitochem 79; 169-176

Xue J, Tsang CW, Gai WP, Malladi CS, Trimble WS, Rostas JA, Robinson PJ (2004). Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. J Neurochem 91 (3): 579-590.

Zavitsanou K, Garrick T, Huang X-F (2004). [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 28: 355-360.


BOOK CHAPTERS

Dean B, and Scarr E (2004). Understanding the pathology of affective disorders: The contribution of post mortem brain studies. In: Affective & Mood Disorders. Ed. Joyce P. and Mitchell P. University of Sydney. Sydney.

Sundram S, Dean B, Copolov DL (2004). The endogenous cannabis system and schizophrenia. In: Castle, DJ, Murray, RM (eds) Marijuana and Madness: Psychiatry and Neurobiology. Cambridge University Press. pp 127-141.